Trinity Biotech
TRIB
71 hedge funds and large institutions have $109M invested in Trinity Biotech in 2016 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 25 closing their positions.
3.32% more ownership
Funds ownership: 0% → 3.32% (+3.3%)
10% less funds holding
Funds holding: 79 → 71 (-8)
24% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 21
24% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 25
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
50% less capital invested
Capital invested by funds: $220M → $109M (-$111M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $162K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FWSM
First Wilshire Securities Management
Pasadena,
California
|
+$6.09M |
| 2 |
SCM
Stonehill Capital Management
New York
|
+$5.09M |
| 3 |
LAM
Lapides Asset Management
Greenwich,
Connecticut
|
+$3.2M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3M |
| 5 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$1.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
ACK Asset Management
Greenwich,
Connecticut
|
-$12.9M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$11.3M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$6.57M |
| 4 |
PCA
Prospect Capital Advisors
Sausalito,
California
|
-$5.41M |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$5.3M |
TRIB Hedge Fund Activity: Q4 2016 in Review
71 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q4 2016, worth a combined $109M — down 50% from $220M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of TRIB and 19 opened new positions — a net loss of 6 holders — while 21 trimmed existing stakes and 16 added.
The largest buyer was First Wilshire Securities Management, opening a new position worth an estimated $6.09M. The largest seller was ACK Asset Management, exiting entirely with an estimated $12.9M sold.
- 71 institutional investors held Trinity Biotech (TRIB) as of Q4 2016, down from 79 in Q3 2016.
- Funds reported $109M of Trinity Biotech stock for Q4 2016, down 50% quarter-over-quarter.
- 19 funds opened new Trinity Biotech positions in Q4 2016 and 25 closed out, a net change of -6 holders.
- The largest Trinity Biotech buyer in Q4 2016 was First Wilshire Securities Management, an estimated $6.09M added.
- The largest Trinity Biotech seller in Q4 2016 was ACK Asset Management, an estimated $12.9M sold.
Based on aggregated 13F filings for Q4 2016.